BrainAurora Medical Technology (HKG:6681) booked 314.9 million yuan in attributable loss for 2025, widening from 198.3 million yuan in 2024, according to a Hong Kong bourse filing Tuesday.
Shares of the digital diagnostics and therapies provider gained over 2% in afternoon trade Wednesday.
Loss per share was 0.27 yuan, compared with 0.23 yuan in the prior year.
Revenue rose 80% year on year to 220 million yuan, figures showed.
The company did not declare a dividend for the year.